Is the Lloyds share price outstanding value or a value trap?

G A Chester discusses popular FTSE 100 stock Lloyds, where all the popular indicators of value are screaming ‘buy’.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The ‘Boris bounce’ didn’t last long for Lloyds (LSE: LLOY). Its share price peaked at 67.25p on 16 December, the Monday after the general election. By mid-January, it was back below 60p. The market evidently had second thoughts about the FTSE 100 bank’s prospects long before its results last week and the broad market sell-off this week.

The shares closed yesterday at 52p. Most brokers, analysts and media tipsters are bullish on the stock, as they have been for years. Indeed, a majority reckon it offers outstanding value. Against that, a not insignificant minority argue it’s a value trap. I’ve been in the latter camp for a good while. But I think it’s now quite a conundrum. I’m asking myself if it could finally be time to back the Black Horse.

Cheap

Purely on the common numerical indicators of value, Lloyds looks cheap. The current share price is 1.02 times the tangible net asset value (TNAV) of 50.8p a share reported in its results.

It’s at 14.9 times earnings of 3.5p a share. And with earnings forecast to zoom to 6.8p this year, the multiple comes down to just 7.6.

Meanwhile, a dividend of 3.37p gives a yield of 6.5%. And this is expected to rise to 6.7% this year on forecasts of an increase in the payout to 3.5p.

As I say, Lloyds looks cheap.

Economic cycle

Banks are highly geared to the health of the wider economy. As such, they fare badly in an economic downturn. There’s a risk the spread of the coronavirus could tip the global economy into a recession, and a risk the Brexit divorce could spark a UK recession too.

Even if neither happens, Lloyds will face a recession at some point. And with the current economic cycle looking long in the tooth by historical standards, a recession is looming ever closer on the horizon. Furthermore, with UK consumers and businesses over-indebted and under-saved like never before, this recession could be a particularly severe one.

Rising bad debts

Insolvency specialist Begbies Traynor has been tracking the health of the UK economy since 2004 in its quarterly ‘Red Flag Alert’ reports. The latest shows that at the end of 2019, almost half a million UK businesses were in “significant financial distress” — the highest level since its reports began.

Lloyds’ latest results, may be an unpleasant taste of things to come. It reported a 38% rise in bad debt impairments to £1.3bn (on a pre-impairment profit of £8.8bn). In the last recession, impairments reached £16.7bn.

Here’s what I’d buy

Lloyds undoubtedly looks cheap on the valuation metrics. I’m almost tempted, but at this stage of the economic cycle I’m still more inclined to see it as a value trap, and to avoid it. Particularly, as the recent market sell-off means many quality defensive businesses are now trading at attractive valuations.

If I was in the market for blue-chip stocks today, I’d be buying Diageo, GlaxoSmithKline and Unilever (among others). Plus one or two of my favoured recovery prospects, notably BT.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended Diageo and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »